Literature DB >> 24857340

Sex and gender influences on pharmacological response: an overview.

Flavia Franconi1, Ilaria Campesi.   

Abstract

Research on the specific effects of sex and gender on pharmacokinetics and pharmacodynamics, as well as safety profile tolerability and drug efficacy, of medications remain meager because female animals and women have only recently been included in the pharmacological domain. To date, the influence of sex and gender on access to care and emotional factors, including patients and care provider dyads, the placebo effect, adherence, and safety profiles, are discussed. Furthermore, differences in drug responses, mainly for antidiabetic drugs, have been described. However, further studies are needed to explore the impact of sex and gender on reaching the most appropriate and tailored prescription for each patient, regardless of sex and gender.

Entities:  

Keywords:  adherence; antidiabetic drugs; drug adverse effect; gender; medication; sex

Mesh:

Substances:

Year:  2014        PMID: 24857340     DOI: 10.1586/17512433.2014.922866

Source DB:  PubMed          Journal:  Expert Rev Clin Pharmacol        ISSN: 1751-2433            Impact factor:   5.045


  30 in total

1.  Androgen-mediated sex bias impairs efficiency of leukotriene biosynthesis inhibitors in males.

Authors:  Simona Pace; Carlo Pergola; Friederike Dehm; Antonietta Rossi; Jana Gerstmeier; Fabiana Troisi; Helmut Pein; Anja M Schaible; Christina Weinigel; Silke Rummler; Hinnak Northoff; Stefan Laufer; Thorsten J Maier; Olof Rådmark; Bengt Samuelsson; Andreas Koeberle; Lidia Sautebin; Oliver Werz
Journal:  J Clin Invest       Date:  2017-07-24       Impact factor: 14.808

2.  Sex and gender considerations in Canadian clinical practice guidelines: a systematic review.

Authors:  Cara Tannenbaum; Barbara Clow; Margaret Haworth-Brockman; Patrice Voss
Journal:  CMAJ Open       Date:  2017-02-10

3.  Sex ratio in multiple sclerosis mortality over 65 years; an age-period-cohort analysis in Norway.

Authors:  Ola Nakken; Jonas Christoffer Lindstrøm; Trygve Holmøy
Journal:  J Neurol       Date:  2018-03-21       Impact factor: 4.849

Review 4.  Put "gender glasses" on the effects of phenolic compounds on cardiovascular function and diseases.

Authors:  Ilaria Campesi; Maria Marino; Manuela Cipolletti; Annalisa Romani; Flavia Franconi
Journal:  Eur J Nutr       Date:  2018-04-25       Impact factor: 5.614

5.  Representation of Women and Minorities in Clinical Trials for New Molecular Entities and Original Therapeutic Biologics Approved by FDA CDER from 2013 to 2015.

Authors:  Alice Chen; Hilary Wright; Hawi Itana; Merina Elahi; Ayomide Igun; Guoxing Soon; Anne R Pariser; Emmanuel O Fadiran
Journal:  J Womens Health (Larchmt)       Date:  2017-10-19       Impact factor: 2.681

Review 6.  Metabolic control and sex: A focus on inflammatory-linked mediators.

Authors:  Darren C Henstridge; Julie Abildgaard; Birgitte Lindegaard; Mark A Febbraio
Journal:  Br J Pharmacol       Date:  2019-04-21       Impact factor: 8.739

Review 7.  Sex as a biological variable in the pathology and pharmacology of neurodegenerative and neurovascular diseases.

Authors:  Pedram Honarpisheh; Louise D McCullough
Journal:  Br J Pharmacol       Date:  2019-05-21       Impact factor: 8.739

Review 8.  Polypharmacy and Cardiovascular Diseases: Consideration for Older Adults and Women.

Authors:  Shreya Patel; Manish Kumar; Craig J Beavers; Saad Karamat; Fawaz Alenezi
Journal:  Curr Atheroscler Rep       Date:  2022-07-21       Impact factor: 5.967

9.  Sex- and Gender-Based Pharmacological Response to Drugs.

Authors:  Franck Mauvais-Jarvis; Heiner K Berthold; Ilaria Campesi; Juan-Jesus Carrero; Santosh Dakal; Flavia Franconi; Ioanna Gouni-Berthold; Mark L Heiman; Alexandra Kautzky-Willer; Sabra L Klein; Anne Murphy; Vera Regitz-Zagrosek; Karen Reue; Joshua B Rubin
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

Review 10.  Sex is a defining feature of neuroimaging phenotypes in major brain disorders.

Authors:  Lauren E Salminen; Meral A Tubi; Joanna Bright; Sophia I Thomopoulos; Alyssa Wieand; Paul M Thompson
Journal:  Hum Brain Mapp       Date:  2021-05-05       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.